跳转至内容
Merck
CN

A76958

Sigma-Aldrich

氨基吡嗪

98%

别名:

2-氨基哌嗪

登录查看公司和协议定价

选择尺寸


关于此项目

经验公式(希尔记法):
C4H5N3
化学文摘社编号:
分子量:
95.10
Beilstein:
107025
EC 号:
MDL编号:
UNSPSC代码:
12352100
PubChem化学物质编号:
NACRES:
NA.22
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

方案

98%

表单

crystals

mp

118-120 °C (lit.)

SMILES字符串

Nc1cnccn1

InChI

1S/C4H5N3/c5-4-3-6-1-2-7-4/h1-3H,(H2,5,7)

InChI key

XFTQRUTUGRCSGO-UHFFFAOYSA-N

正在寻找类似产品? 访问 产品对比指南

应用

四组分合成咪唑烷类的基质。

储存分类代码

11 - Combustible Solids

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable

个人防护装备

dust mask type N95 (US), Eyeshields, Gloves


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Synthetic Communications, 37, 247-247 (2007)
J F Cavalier et al.
Bioorganic & medicinal chemistry, 9(4), 1037-1044 (2001-05-17)
A series of 5-aryl- and 3,5-bis-aryl-2-amino-1,4-pyrazine derivatives 4 and 6, and related imidazolopyrazinones 7, has been synthesized, the aryl groups of which are catechol and/or phenol substituents. These compounds, tested against human keratinocyte cells stressed by UVB irradiation, showed high
Abdullah M Asiri et al.
Molecules (Basel, Switzerland), 12(8), 1796-1804 (2007-10-26)
New Schiff bases derived from 2-aminopyridene and 2-aminopyrazine have been synthesized. The UV-Visible spectra of the compounds have been investigated in acetonitrile and toluene. The compounds were in tautomeric equilibrium (enol-imine O- H...N, keto-amine O...H-N forms) in polar and nonpolar
Jan Zitko et al.
Molecules (Basel, Switzerland), 23(9) (2018-09-21)
Three series of N-(pyrazin-2-yl)benzamides were designed as retro-amide analogues of previously published N-phenylpyrazine-2-carboxamides with in vitro antimycobacterial activity. The synthesized retro-amides were evaluated for in vitro growth inhibiting activity against Mycobacterium tuberculosis H37Rv (Mtb), three non-tuberculous mycobacterial strains (M. avium
Anna Eriksson et al.
Biochemical pharmacology, 80(10), 1507-1516 (2010-08-14)
Aberrant signal transduction by mutant or overexpressed protein kinases has emerged as a promising target for treatment of acute myeloid leukemia (AML). We here present a novel low molecular weight kinase inhibitor, AKN-032, targeting the FMS-like tyrosine kinase 3 (FLT3)

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持